{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:12:53Z","timestamp":1775308373924,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607A2023\/04"],"award-info":[{"award-number":["IN607A2023\/04"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014569","name":"Spanish Society of Hospital Pharmacy","doi-asserted-by":"publisher","award":["FEFH 2021-2022"],"award-info":[{"award-number":["FEFH 2021-2022"]}],"id":[{"id":"10.13039\/501100014569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017210","name":"Health Research Institute of Santiago de Compostela","doi-asserted-by":"publisher","award":["IDISPOS1782\/2024"],"award-info":[{"award-number":["IDISPOS1782\/2024"]}],"id":[{"id":"10.13039\/100017210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejps.2026.107459","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:00:49Z","timestamp":1770253249000},"page":"107459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-term clinical outcomes of 0.015 % tacrolimus HP\u03b2CD eye drops in ocular surface inflammatory disorders"],"prefix":"10.1016","volume":"219","author":[{"given":"Mar\u00eda","family":"Puente-Iglesias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3717-5693","authenticated-orcid":false,"given":"Andrea","family":"Cuartero-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Touri\u00f1o-Peralba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Rodr\u00edguez-Ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Gir\u00e1ldez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Yebra-Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Torres-Sangiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gonz\u00e1lez-Barcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Zarra-Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J","family":"Otero-Espinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anxo","family":"Fern\u00e1ndez-Ferreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Castro-Balado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107459_bib0070","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Ficha T\u00e9cnica Liquifilm L\u00e1grimas 14 Mg\/Ml Colirio En Soluci\u00f3n. Available online: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/58308\/FT_58308.html (accessed on 21 March 2024)."},{"key":"10.1016\/j.ejps.2026.107459_bib0008","year":"2024","journal-title":"Ficha T\u00e9c. Progr. 5 Mg\/Ml Conc. Para Soluc. Para Perfus. Available online"},{"key":"10.1016\/j.ejps.2026.107459_bib0035","year":"2024","journal-title":"Ficha T\u00e9c. VOLTAREN 1 Mg\/Ml COLIRIO EN SOLUC. Available online"},{"key":"10.1016\/j.ejps.2026.107459_bib0026","doi-asserted-by":"crossref","first-page":"400","DOI":"10.18502\/jovr.v14i4.5437","article-title":"Topical tacrolimus as an adjunct to conventional therapy for stromal herpetic keratitis: A randomized clinical trial","volume":"14","author":"Akbari","year":"2019","journal-title":"J. Ophthalmic. Vis. Res."},{"issue":"1","key":"10.1016\/j.ejps.2026.107459_bib0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/11206721231172236","article-title":"Topical tacrolimus in high-risk corneal transplants","volume":"34","author":"Bernardes","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0034","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107459_bib0072","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41598-021-04569-x","article-title":"Mining for novel cyclomaltodextrin glucanotransferases unravels the carbohydrate metabolism pathway via cyclodextrins in thermoanaerobacterales","volume":"12","author":"Centeno-Leija","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107459_bib0027","first-page":"27","author":"Dhaliwal","year":"2008","journal-title":"Long-Term Use Top. Tacrolimus (FK506) High-Risk Penetrating Keratoplasty"},{"key":"10.1016\/j.ejps.2026.107459_bib0010","year":"2024","journal-title":"Quest. Answ. Cyclodext. Used Excip. Med. Prod. Hum. Use Available online"},{"key":"10.1016\/j.ejps.2026.107459_bib0028","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ICL.0000000000000162","article-title":"Evaluation of effect of topical tacrolimus treatment on herpetic stromal keratitis in a rat model","volume":"42","author":"Eri\u015f","year":"2016","journal-title":"Eye Contact Lens: Sci. Clin. Pract."},{"key":"10.1016\/j.ejps.2026.107459_bib0016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.oftal.2010.12.010","article-title":"Study of tear function and the conjunctival surface in diabetic patients]","volume":"86","author":"Figueroa-Ortiz","year":"2011","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0071","unstructured":"Foods and Drugs Administration (FDA). Highlights of prescribing information AzaSite\u00ae (Azithromycin Ophthalmic Solution) 1 % sterile topical ophthalmic drops initial U.S. Approval: 2007 Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/050810s014lbl.pdf (accessed on 11 May 2025)."},{"key":"10.1016\/j.ejps.2026.107459_bib0054","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives","volume":"11","author":"Gaballa","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2026.107459_bib0011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/pharmaceutics13020149","article-title":"Development and characterization of a tacrolimus\/hydroxypropyl-\u03b2-cyclodextrin eye drop","volume":"13","author":"Garc\u00eda-Otero","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107459_bib0012","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3390\/pharmaceutics13101737","article-title":"Anti-inflammatory effect of Tacrolimus\/hydroxypropyl-\u03b2-cyclodextrin eye drops in an endotoxin-induced uveitis model","volume":"13","author":"Garc\u00eda-Otero","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107459_bib0043","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/jop.2022.0187","article-title":"Dietary alcohol consumption elicits corneal toxicity through the generation of cellular oxidative stress","volume":"39","author":"Ghosh","year":"2023","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107459_bib0058","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtos.2018.11.003","article-title":"The impact of dry eye disease treatment on patient satisfaction and quality of life: A review","volume":"17","author":"Gomes","year":"2019","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejps.2026.107459_bib0053","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/ph14111201","article-title":"Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems","volume":"14","author":"Gupta","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2026.107459_bib0047","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jfo.2018.12.001","article-title":"Tear film analysis and evaluation of optical quality: A review of the literature","volume":"42","author":"Herbaut","year":"2019","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0006","article-title":"Advancing treatment in atopic dermatitis: A comprehensive review of clinical efficacy, safety, and comparative insights into corticosteroids, calcineurin inhibitors, and phosphodiesterase-4 inhibitors as topical therapies","volume":"16","author":"Hernandez","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejps.2026.107459_bib0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","article-title":"Proper method for calculating average visual acuity","volume":"13","author":"Holladay","year":"1997","journal-title":"J. Refract. Surg."},{"key":"10.1016\/j.ejps.2026.107459_bib0064","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.3390\/pharmaceutics14102176","article-title":"Highlighting the microbial contamination of the dropper tip and cap of In-use eye drops, the associated contributory factors, and the risk of infection: A past-30-years literature review","volume":"14","author":"Iskandar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107459_bib0063","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/09273948.2019.1699122","article-title":"Adherence to topical medication in patients with inflammatory eye disease","volume":"29","author":"Javidi","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejps.2026.107459_bib0048","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2025.05.039","article-title":"TFOS DEWS III: management and therapy","volume":"279","author":"Jones","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0059","doi-asserted-by":"crossref","DOI":"10.31031\/ICP.2020.02.000537","article-title":"Dry Eye Disease: A comprehensive review","volume":"2","author":"Kaiti","year":"2020","journal-title":"ICP"},{"key":"10.1016\/j.ejps.2026.107459_bib0044","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ophtha.2011.11.015","article-title":"Oral alcohol administration disturbs tear film and ocular surface","volume":"119","author":"Kim","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejps.2026.107459_bib0005","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","article-title":"FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics","volume":"40","author":"Kino","year":"1987","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ejps.2026.107459_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40629-016-0006-7","volume":"26","author":"Klimek","year":"2017","journal-title":"Allergo J. Int."},{"key":"10.1016\/j.ejps.2026.107459_bib0060","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.4103\/ijo.IJO_1804_21","article-title":"Evaluation of ocular surface and tear function - A review of current approaches for dry eye","volume":"70","author":"Koh","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0031","article-title":"Conjunctival melanoma following cornea transplant from a cancer donor: A case report","volume":"29","author":"Kwitko","year":"2023","journal-title":"Am. J. Ophthalmol. Case Rep."},{"issue":"9","key":"10.1016\/j.ejps.2026.107459_bib0002","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/all.13786","article-title":"Management of ocular allergy","volume":"74","author":"Leonardi","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.ejps.2026.107459_bib0051","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.clae.2018.12.003","article-title":"Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study","volume":"42","author":"Lievens","year":"2019","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ejps.2026.107459_bib0024","article-title":"Topical corticosteroids for dry eye","volume":"2022","author":"Liu","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejps.2026.107459_bib0033","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-0420.2002.800205.x","article-title":"Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye","volume":"80","author":"Loftsson","year":"2002","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.ejps.2026.107459_bib0032","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.04.010","article-title":"Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye","volume":"531","author":"Loftsson","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107459_bib0004","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2018.04.038","article-title":"Preclinical characterization and clinical evaluation of Tacrolimus eye drops","volume":"120","author":"Luaces-Rodr\u00edguez","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107459_bib0017","author":"Mangione","year":"2000","journal-title":"Natl. Eye Inst. 25-Item Vis. Funct. Quest. (VFQ-25)"},{"key":"10.1016\/j.ejps.2026.107459_bib0003","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/pharmaceutics12060570","article-title":"Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation","volume":"12","author":"Mazet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107459_bib0066","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/jps.20976","article-title":"Antimicrobial preservative use in parenteral products: past and present","volume":"96","author":"Meyer","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107459_bib0039","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16191-6","article-title":"Alterations in the ocular surface and tear film following keratoplasty","volume":"12","author":"Meyer","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107459_bib0055","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10384-020-00774-9","article-title":"Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseases","volume":"64","author":"Miyazaki","year":"2020","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106206","article-title":"Current trends in pharmaceutical treatment of dry eye disease: A review","volume":"175","author":"Mohamed","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107459_bib0046","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1542-0124(12)70233-1","article-title":"The tear film and the optical quality of the eye","volume":"8","author":"Mont\u00e9s-Mic\u00f3","year":"2010","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejps.2026.107459_bib0009","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.13-11717","article-title":"Analysis of ethanol effects on corneal epithelium","author":"Oh","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2026.107459_bib0068","doi-asserted-by":"crossref","first-page":"413","DOI":"10.59566\/IJBS.2006.2413","article-title":"Intraoperative ethanol treatment as an adjuvant therapy of pterygium excision","volume":"2","author":"Ophthalmology","year":"2006","journal-title":"Int. J Biomed Sci"},{"key":"10.1016\/j.ejps.2026.107459_bib0022","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40271-022-00586-8","article-title":"Patient medication preferences for managing dry eye disease: the importance of medication side effects","volume":"15","author":"Ozdemir","year":"2022","journal-title":"Patient"},{"key":"10.1016\/j.ejps.2026.107459_bib0052","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jfo.2018.03.007","article-title":"Assessment of ocular redness measurements obtained with Keratograph 5M and correlation with subjective grading scales","volume":"41","author":"P\u00e9rez-Bartolom\u00e9","year":"2018","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbamem.2016.12.010","article-title":"The effect of repeated lateral compression and expansions mimicking blinking on selected tear film polar lipid monofilms","volume":"1859","author":"Patterson","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejps.2026.107459_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2026.107459_bib0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eimc.2022.07.001","volume":"40","year":"2022","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.ejps.2026.107459_bib0014","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.3390\/ijms25189847","article-title":"Clinical effectiveness, safety, and compliance of two compounded formulations of Tacrolimus eye drops: an open-label, sequential prospective study","volume":"25","author":"Puente-Iglesias","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.ejps.2026.107459_bib0067","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/pharmaceutics17020196","article-title":"Influence of ethanol as a preservative in topical formulation on the dermal penetration efficacy of active compounds in healthy and barrier-disrupted skin","volume":"17","author":"Raab","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107459_bib0042","first-page":"32","article-title":"Toxic external exposure leading to ocular surface injury","volume":"7","author":"Rauchman","year":"2023","journal-title":"Vis"},{"key":"10.1016\/j.ejps.2026.107459_bib0013","year":"2024","journal-title":"Agencia Esp. Medicam. Prod. Sanit."},{"key":"10.1016\/j.ejps.2026.107459_bib0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jfo.2017.09.005","article-title":"Ciclosporine A topique et risque de n\u00e9oplasie de la surface oculaire","volume":"41","author":"Rouimi","year":"2018","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0029","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1357633X20970398","article-title":"Is your vision blurry? A systematic review of home-based visual acuity for telemedicine","volume":"29","author":"Samanta","year":"2023","journal-title":"J. Telemed. Telecare"},{"key":"10.1016\/j.ejps.2026.107459_bib0021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.11.9.16","article-title":"The effect of anti-inflammatory topical ophthalmic treatments on In vitro corneal epithelial cells","volume":"11","author":"Sella","year":"2022","journal-title":"Trans. Vis. Sci. Tech."},{"key":"10.1016\/j.ejps.2026.107459_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/07853890.2022.2157477","article-title":"Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists","volume":"55","author":"Sheppard","year":"2023","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejps.2026.107459_bib0041","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/ICL.0000000000000725","article-title":"The early effects of alcohol consumption on functional visual acuity, tear functions, and the ocular surface","volume":"47","author":"Simsek","year":"2021","journal-title":"Eye Contact. Lens."},{"key":"10.1016\/j.ejps.2026.107459_bib0056","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/s41433-020-01282-3","article-title":"Work productivity among Sj\u00f6gren\u2019s syndrome and Non-Sj\u00f6gren\u2019s dry eye patients: A systematic review and meta-analysis","volume":"35","author":"Sivakumar","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.ejps.2026.107459_bib0019","unstructured":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria. Grupo de Trabajo Sobre Adherencia. EVA - Escala Anal\u00f3gica Visual de Adherencia Available online: https:\/\/gruposdetrabajo.sefh.es\/adhefar\/todos-eva-escala-analogica-visual-de-adherencia."},{"key":"10.1016\/j.ejps.2026.107459_bib0061","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajo.2025.05.040","article-title":"Tfos Dews iii: digest","volume":"279","author":"Stapleton","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0062","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact on quality of life and vision","volume":"1","author":"Uchino","year":"2013","journal-title":"Curr. Ophthalmol. Rep."},{"key":"10.1016\/j.ejps.2026.107459_bib0065","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/OPTH.S211611","article-title":"The use of preservatives in dry eye drops","author":"Walsh","year":"2019","journal-title":"OPTH"},{"key":"10.1016\/j.ejps.2026.107459_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-022-02280-7","article-title":"Effect of artificial tears on dynamic optical quality in patients with dry eye disease","volume":"22","author":"Wei","year":"2022","journal-title":"BMC. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0038","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1631\/jzus.B1700095","article-title":"Assessments of tear meniscus height, tear film thickness, and corneal epithelial thickness after deep anterior lamellar keratoplasty","volume":"19","author":"Xie","year":"2018","journal-title":"J. Zhejiang. Univ. Sci. B"},{"key":"10.1016\/j.ejps.2026.107459_bib0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13223-021-00513-w","article-title":"Long-term outcomes of 0.1 % tacrolimus eye drops in eyes with severe allergic conjunctival diseases","volume":"17","author":"Yazu","year":"2021","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.ejps.2026.107459_bib0037","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10792-020-01410-8","article-title":"Changes in corneal thickness, upper and lower tear film in seasonal allergic conjunctivitis by steroid treatment: anterior segment optical coherence tomography study","volume":"40","author":"Yeter","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0069","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00417-023-05977-7","article-title":"Bacterial contamination of multi-use antibiotic steroid eye ointments and drops","volume":"261","author":"Yilmaz","year":"2023","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0057","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: A decision tree analysis","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ejps.2026.107459_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-021-02233-6","article-title":"Analysis of the first tear film break-up point in Sj\u00f6gren\u2019s syndrome and Non-Sj\u00f6gren\u2019s syndrome dry eye patients","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC. Ophthalmol."},{"key":"10.1016\/j.ejps.2026.107459_bib0049","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/OPX.0b013e3181824dc4","article-title":"Effect of viscosity on tear drainage and ocular residence time","volume":"85","author":"Zhu","year":"2008","journal-title":"Optom. Vis. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:20:08Z","timestamp":1775305208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":72,"alternative-id":["S0928098726000333"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107459","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term clinical outcomes of 0.015 % tacrolimus HP\u03b2CD eye drops in ocular surface inflammatory disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107459"}}